An in vitro study of the protective effect of relaxin on brain tissue under ischemic stress

Annals of the New York Academy of Sciences

Volumn 1160, Issue , 2009, Pages 265-268

  Wilson, Brian C ^a   Rappaport, Rebecca ^a  

^a ACADIA UNIVERSITY   (Canada)

Author keywords

Ischemia; Neuroprotection; Organotypic culture; Relaxin

Indexed keywords

RELAXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN ISCHEMIA; BRAIN NERVE CELL; BRAIN SLICE; BRAIN TISSUE; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; IN VITRO STUDY; NEUROPROTECTION; NONHUMAN; RAT; TISSUE CULTURE;

RATTUS;

EID: 64549146237     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2008.03806.x     Document Type: Conference Paper

References (15)

1. Sherwood, O.D. 2004. Relaxin's physiological roles and other diverse actions. Endocr. Rev. 25: 205-234.
2. Dschietzig, T., C. Richter, C. Bartsch, et al. 2001. The pregnancy hormone relaxin is a player in human heart failure. Eur. Heart J. 22: 233-233.
3. Failli, P., S. Nistri, S. Quattrone, et al. 2002. Relaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells. FASEB J. 16: 252-254.
4. Bani, D., E. Masini, M.G. Bello, et al. 1998. Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart. Am. J. Pathol. 152: 1367-1376.
5. Masini, E., D. Bani, M. Bigazzi, et al. 1994. Effects of relaxin on mast cells. In vitro and in vivo studies in rats and guinea pigs. J. Clin. Investig. 94: 1974-1980.
6. Masini, E., M.G. Di Bello, D. Bani, et al. 1995. Relaxin inhibits histamine release from mast cells: Involvement of nitric oxide production. Inflamm. Res. 44 (Suppl. 1): S12-S13.
7. Masini, E., S. Nistri, A. Vannacci, et al. 2004. Relaxin inhibits the activation of human neutrophils: Involvement of the nitric oxide pathway. Endocrinology 145: 1106-1112.
8. Nistri, S., L. Chiappini, C. Sassoli, et al. 2003. Relaxin inhibits lipopolysaccharide-induced adhesion of neutrophils to coronary endothelial cells by a nitric oxidemediated mechanism. FASEB J. 17: 2109-2111.
9. Masini, E., D. Bani, M.G. Bello, et al. 1997. Relaxin counteracts myocardial damage induced by ischemia-reperfusion in isolated guinea pig hearts: Evidence for an involvement of nitric oxide. Endocrinology 138: 4713-4720.
10. Saleh, T.M., A.E. Cribb & B.J. Connell. 2001. Reduction in infarct size by local estrogen does not prevent autonomic dysfunction after stroke. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281: R2088-R2095.
11. Wilson, B.C., B. Connell & T.M. Saleh. 2006. Relaxin-induced reduction of infarct size in male rats receiving MCAO is dependent on nitric oxide synthesis and not estrogenic mechanisms. Neurosci. Lett. 393: 160-164.
12. Wilson, B.C., P. Milne & T.M. Saleh. 2005. Relaxin pretreatment decreases infarct size in male rats after middle cerebral artery occlusion. Ann. N. Y. Acad. Sci. 1041: 223-228.
13. Canadian Council on Animal Care. 1993. In Guide to the Care and Use of Experimental Animals. E.D. Olfert, B.M. Cross & A.A. McWilliam, Eds.: 195. Canadian Council on Animal Care. Ottawa, Ontario, Canada.
14. Strasser, U. & G. Fischer. 1995. Quantitative measurement of neuronal degeneration in organotypic hippocampal cultures after combined oxygen/glucose deprivation. J. Neurosci. Methods 57: 177-186.
15. Rossi, D.J., J.D. Brady & C. Mohr. 2007. Astrocyte metabolism and signaling during brain ischemia. Nat. Neurosci. 10: 1377-1386.